← Evidence map

ArticleFrontiers in pharmacology2022

IGF2BP1, a New Target to Overcome Drug Resistance in Melanoma?

Yufeng Xi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2022
2023
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35935853